Evidence map›Paper›PMID 33509131›Full record

Observational studyBMC pulmonary medicine2021

Clinico-epidemiological characteristics of men and women with a new diagnosis of chronic obstructive pulmonary disease: a database (SIDIAP) study.

Josep Montserrat-Capdevila, Josep Ramon Marsal, Marta Ortega, Maria Teresa Castañ-Abad, Miquel Alsedà, Ferran Barbé, Pere Godoy

Abstract readObservational Study
In one paragraph

Observational study in BMC pulmonary medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Josep Montserrat-CapdevilaUnitat Docent Multiprofessional d'Atenció Familiar i Comunitària (UDMAFiC) Lleida-ICS, Gerència Territorial de Lleida ICS, Lleida, Catalonia, Spain. jmontser@alumni.unav.es.ORCID http://orcid.org/0000-0003-1878-5064
Josep Ramon MarsalCardiovascular Epidemiology Unit, Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain.
Marta OrtegaAtenció Primària, Institut Català de la Salut (ICS), Lleida, Catalonia, Spain.
Maria Teresa Castañ-AbadAtenció Primària, Institut Català de la Salut (ICS), Lleida, Catalonia, Spain.
Miquel AlsedàFaculty of Medicine, Universitat de Lleida (UdL), Lleida, Catalonia, Spain.
Ferran BarbéFaculty of Medicine, Universitat de Lleida (UdL), Lleida, Catalonia, Spain.
Pere GodoyFaculty of Medicine, Universitat de Lleida (UdL), Lleida, Catalonia, Spain.

Funding

IRBLleida/IDIAP .
6 · The paper itself

Abstract

backgroundThe risk of developing Chronic Obstructive Pulmonary Disease (COPD), the associated comorbidities and response to bronchodilators might differ in men and women. The objective of this study was to determine the prevalence of COPD and the clinic-epidemiological characteristics of primary care patients with COPD according to gender.

methodsThis is a cross-sectional study using electronic healthcare records Catalonia (Spain), during the 01/01/2012-31/12/2017 period. Patients from the SIDIAP database (System for the Development of Research in Primary Care) were included (5,800,000 patients registered in 279 primary care health centres). Clinic-demographic characteristics, comorbidities and blood tests results were collected for each patient. Adjusted OR (ORa) with logistic regression methods were used to determine variables associated with men and women.

resultsFrom an initial sample of 800,899 people, 24,135 (3%) were considered COPD patients, and 22.9%were women. The most common risk factors in women were bronchiectasis (ORa = 20.5, SD = 19.5-21.6), age > 71 years (ORa = 18.8; SD = 17.3-20.5), cor pulmonale (ORa = 5.2; SD = 4.3-6.7) and lung cancer (ORa = 3.6, SD = 3.2-4.0). Men and women presented the same comorbidities, though the strength of association was different for each gender.

conclusionsPatients suffering high comorbidity rates. Comorbidities are similar in men and women, although the strength of association varies according to gender. Women are more susceptible to the harmful effects of smoking and present a higher proportion of bronchiectasis and OSAS.

Indexed as

AdultAgedAged, 80 and overAge DistributionBronchiectasisComorbidityCross-Sectional StudiesDatabases, FactualFemaleHumansLogistic ModelsLung NeoplasmsMaleMiddle AgedMultivariate AnalysisPrevalenceChronic obstructive pulmonary diseaseEpidemiologyPrevalence

Identifiers

PMID33509131
PMCPMC7842000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.